METHYL METHACRYLATE FOR CRANIPLASTY

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2019-01-18 for METHYL METHACRYLATE FOR CRANIPLASTY manufactured by Wrights Lane Synthes Usa Products Llc.

Event Text Entries

[133687894] There are multiple patients. All known information is provided in the journal article. 510k: this report is for an unknown cranios calcium phosphate cement /unknown lot. Part and lot number are unknown; udi number is unknown. There are multiple dates of implantation between march 2013 and december 2015. Complainant part is not expected to be returned for manufacturer review/investigation. Without a lot number the device history records review could not be completed. Product was not returned. Based on the information available, it has been determined that no corrective and/or preventative action is proposed. This complaint will be accounted for and monitored via post market surveillance activities. If additional information is made available, the investigation will be updated as applicable. (b)(4). Device was used for treatment, not diagnosis. If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[133687895] This report is being filed after the review of the following journal article: feroze, ra. , agarwal, n. And sekula, rf. (2018), utility of calcium phosphate cement cranioplasty following supraorbital approach for tumor resection, international journal of neuroscience, pages 1-6 (usa). The aim of this retrospective analysis study of a prospectively maintained database is to demonstrate the efficacy of calcium phosphate cement cranioplasty following a supraorbital approach for tumor resection. Between march 2013 and december 2015, a total of 8 patients (1 male and 7 female) with a mean age of 67 years (range, 55-82 years) underwent a supraorbital approach followed by cement cranioplasty. To achieve a watertight, calcium phosphate cement cranioplasty, 10 ccs of sodium hyaluronate solution was vigorously mixed with 17 grams of calcium phosphate powder in a sterile fashion for 45-90 seconds, resulting in a moldable paste (cranios reinforced, synthes; 74 hydroset, stryker). The cohort had a mean follow-up of approximately 3. 1 months (range, 0. 5-7 months). The following complications were reported: a (b)(6) female required revision surgery for residual tumor. 2 patients required readmissions for surgical revision. This report is for an unknown synthes calcium phosphate cement (cranios reinforced). This is report 1 of 1 for (b)(4). A copy of the literature article is being submitted with this medwatch.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2939274-2019-55933
MDR Report Key8261423
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2019-01-18
Date of Report2018-12-27
Date Mfgr Received2018-12-27
Date Added to Maude2019-01-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKARA DITTY-BOVARD
Manufacturer Street1302 WRIGHTS LANE EAST
Manufacturer CityWEST CHESTER PA 19380
Manufacturer CountryUS
Manufacturer Postal19380
Manufacturer Phone6103142063
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Generic NameMETHYL METHACRYLATE FOR CRANIPLASTY
Product CodeGXP
Date Received2019-01-18
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerWRIGHTS LANE SYNTHES USA PRODUCTS LLC
Manufacturer Address1302 WRIGHTS LANE EAST WEST CHESTER PA 19380 US 19380


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-01-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.